TF and chronic myelogenous leukemia, BCR-ABL1 positive: Using as input microRNAs upregulated in CML-CP LSC-enriched fraction, this analysis detected a significant enrichment in “lipid metabolism” (False Discovery Rate, FDR: 0.0141), “hematopoiesis” (FDR: 0.0217), TF Early growth response 1 (EGR1) (FDR: 0.007), and miR-99b cluster (FDR: 0.0138) (Table 2).